Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities

Phase 3 Completed 101 enrolled Astellas Pharma Inc

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The study objective is to evaluate the efficacy and safety of oral YM150 for prevention of venous thromboembolism in subjects undergoing hip fracture surgery or surgery in the lower extremities.

Timeline

Start: 2009-06
Primary completion: 2010-04
Completion: 2010-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	darexaban	Small molecule	—	Oral

Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities

Summary

Timeline

Drugs

Indications